Detalhe da pesquisa
1.
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 65(7): e27062, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29603593